Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling



Rating:

Share or cite this content

Citations should be made in the following way:
J. Gauldie (Hamilton, Ont, Canada). The fate of lung fibrosis: Reversible or not?. Lung Science Conference 2008 - Lung Injury, Repair and Remodelling

Member's Comments

No comment yet.

Related content which might interest you: Location or origin? What is critical for macrophage propagation of lung fibrosis? Source: Eur Respir J, 51 (3) 1800103; 10.1183/13993003.00103-2018 Year: 2018 Monitoring early lung disease in cystic fibrosis: where are we now? Source: Breathe 2014; 10: 34-47 Year: 2014 Cellular plasticity in lung fibrosis: where are all the fibroblasts coming from? Source: Annual Congress 2012 - PG11 Pulmonary fibrosis Year: 2012 Opening Lecture: Is human pulmonary fibrosis simply lung regeneration without a blueprint? Source: ERS Lung Science Conference 2021 Year: 2021 Cystic fibrosis related pulmonary disease: more structure than function? Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005 Measuring CFTR function in respiratory epithelial cell cultures: step to individualize treatments in cystic fibrosis? Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Lung inflammation in cystic fibrosis: an overlooked therapeutic target? Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age Year: 2020 Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling? Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Combined pulmonary fibrosis and emphysema: A distinct entity? Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Impact of sensitization to Aspergillus fumigatus on lung function in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Oxidative stress in cystic fibrosis lung disease: an early event, but worth targeting? Source: Eur Respir J 2014; 44: 17-19 Year: 2014 What damages the cystic fibrosis lung epithelium: host or microbe? Source: Virtual Congress 2021 – Innate immunity and lung epithelial repair: what really happens? Year: 2021 Tezacaftor-ivacaftor for the treatment of cystic fibrosis: what’s next? Source: International Congress 2018 – Therapeutic breakthroughs Year in Review Year: 2018 Epithelial pIgR: A new player in idiopathic pulmonary fibrosis? Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Is ceramide the missing link between the molecular defect and the lung disease of cystic fibrosis? Source: Breathe 2008; 4: 365 Year: 2008 Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis? Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016